Fig. 3
From: ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL
ARL2 inhibits in vivo tumor formation capability of glioma cells. a The size analysis of subcutaneous tumors measured every four days from nude mice transduce with ARL2 overexpression or control vector transduced U87 cells. b, c Images of mice (b) and subcutaneous (c) tumors at 28th day after subcutaneous transplantation of ARL2 overexpression or control vector transduced U87 cells. d The weight of tumor from nude mice at 28th day after transplantation of U87 cells transduced with ARL2 overexpression or control vector